This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph H. Contiliano and His Retinal Drug-Delivery Invention.
Introduction
Joseph H. Contiliano is an inventor associated with Stewartsville, New Jersey, and Genentech, Inc. His listed patent concerns a device designed to deliver therapeutic agents to the subretinal region of the eye.
Latest Patents
The provided information lists one patent for Contiliano: “Therapeutic Agent Delivery Device with Convergent Lumen.” The apparatus includes an outer cannula and a movable inner cannula with an open distal end configured to pierce the retina. Its lumen delivers two fluids into the subretinal region. Separate supply conduits feed the fluids, and their distal ends are secured to the inner cannula so they move longitudinally with it. This coordinated movement supports fluid delivery as the cannula advances.
Career Highlights
Contiliano’s listed invention addresses the engineering of a specialized ophthalmic delivery device. The patent describes a configuration intended to combine retinal access with the delivery of two fluids through a shared lumen. The supplied information identifies Genentech, Inc. as his company.
Collaborations
Daniel J. Abbott is identified as Contiliano’s coworker. The available information does not specify their roles or describe a particular joint project.
Conclusion
Joseph H. Contiliano’s listed patent presents a coordinated cannula-and-conduit design for delivering therapeutic fluids to the subretinal region, reflecting a focused contribution to ophthalmic device innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
